U.S. Medical Adhesives Market Size, Share & Forecast 2026–2032
Report Highlights
- ✓Country: United States
- ✓Market: Medical Adhesives Market
- ✓Market Size 2024: USD 5.2 billion
- ✓Market Size 2032: USD 8.1 billion
- ✓CAGR: 5.7%
- ✓Base Year: 2025
- ✓Forecast Period: 2026–2032
Analyst Recommendation — Lock Quality Systems Now: Adhesive OEMs should complete QMSR transition audits under 21 CFR Part 820 before February 2, 2026, and secure ISO 10993-1 biocompatibility files for every new chemistry. Gaps will delay 510(k) clearances and trigger FDA inspection findings.
Medical Adhesives in the United States: Market Overview
The U.S. medical adhesives market was valued at USD 5.2 billion in 2024 and is forecast to reach USD 8.1 billion by 2032. Demand concentrates in surgical wound closure, transdermal drug delivery, ostomy care, and device assembly, with hospitals and ambulatory surgical centers consuming the largest share of volume. Structure reflects multinational chemistry producers, medtech conglomerates, and converters supplying tapes, films, and hydrocolloid laminates. Private firms lead product development, while federal policy shapes reimbursement and clearance timing.
Government has been the dominant force in setting market boundaries rather than producing goods. FDA premarket pathways under the Federal Food, Drug, and Cosmetic Act determine which adhesive products reach hospitals, while CMS payment rules under the Social Security Act decide which procedures are reimbursed. Private players including 3M, Avery Dennison Medical, and Henkel have led innovation in pressure-sensitive and cyanoacrylate chemistries, shaping the technology mix more than any federal program.
Policy-Driven Growth in U.S. Medical Adhesives
Three federal mechanisms are pulling demand. First, the Hospital-Acquired Condition Reduction Program under Section 1886(q) of the Social Security Act cuts 1% of Medicare inpatient payments from hospitals in the worst-performing quartile for conditions including surgical site infections. Hospitals respond by favoring advanced incisional dressings and antimicrobial-adhesive closures, raising unit demand per procedure.
Second, Medicare device pass-through under 42 CFR 419.66 provides add-on payments for two to three years to new adhesive-based devices under the Hospital Outpatient Prospective Payment System. Third, the Medical Device User Fee Amendments under MDUFA V, authorized through fiscal year 2027, fund a 90-day FDA review goal for 510(k) submissions, shortening time to market for new sealants and tapes. Each mechanism converts clinical need into reimbursed, clearable product volume.
Regulatory Barriers and Compliance Costs
FDA's Center for Devices and Radiological Health administers premarket notification under Section 510(k) and the Quality Management System Regulation, which amends 21 CFR Part 820 to incorporate ISO 13485:2016 from February 2, 2026. A standard 510(k) user fee exceeded USD 24,000 in fiscal year 2025, and biocompatibility testing under ISO 10993-1 adds months and substantial cost for each new chemistry.
Commerce's Bureau of Industry and Security opened a Section 232 investigation in September 2025 covering medical devices and consumables, including adhesive dressings and tapes. Resulting tariffs would raise input costs for imported acrylic and silicone raw materials. EPA also requires Toxic Substances Control Act premanufacture notices for novel adhesive monomers, adding review time before commercial use.
Policy-Created Opportunities in the United States
The Centers for Medicare & Medicaid Services' Ambulatory Surgical Center Covered Procedures List expansion moves orthopedic and gynecologic procedures into outpatient settings. Each shift creates demand for closure adhesives and incision dressings sized for ASC workflows, where Medline Industries and Cardinal Health hold distribution scale.
Buy American Act provisions in Federal Acquisition Regulation Part 25 favor domestically converted sterile adhesive products in federal procurement, including Department of Veterans Affairs contracts. Converters with U.S. facilities in New Jersey and Massachusetts can capture these awards. Manufacturers should pursue VA Federal Supply Schedule listings to access this demand.
Market at a Glance
| Metric | Detail |
|---|---|
| Market Size 2024 | USD 5.2 billion |
| Market Size 2032 | USD 8.1 billion |
| Growth Rate (CAGR) | 5.7% |
| Most Critical Decision Factor | FDA 510(k) clearance timing and reimbursement eligibility under CMS payment rules |
| Largest Region | Northeast (New Jersey, Massachusetts, Pennsylvania) |
| Competitive Structure | Consolidated; multinational chemistry and medtech firms dominate |
Leading Market Participants
- 3M
- Johnson & Johnson
- Avery Dennison Medical
- H.B. Fuller
- Henkel
- Bostik
- Smith & Nephew
- Medline Industries
- Cardinal Health
- Tredegar Corporation
Regulatory and Policy Environment
The primary legislation is the Federal Food, Drug, and Cosmetic Act, with device provisions added by the Medical Device Amendments of 1976 and fee-funded review timelines set under MDUFA V in the FDA Reauthorization Act of 2017. FDA's Center for Devices and Radiological Health enforces premarket clearance, unique device identification under 21 CFR Part 830, and labeling rules under 21 CFR Part 801. The QMSR takes effect February 2, 2026.
Compared with the European Union, where Regulation (EU) 2017/745 imposes notified-body certification with transition deadlines extending to 2027 and 2028, the U.S. 510(k) pathway is faster but relies on substantial equivalence. Japan's PMDA and Health Canada's Medical Devices Regulations (SOR/98-282) require separate local registrations. Upcoming changes include MDUFA VI negotiations ahead of the 2027 reauthorization and the pending Section 232 determination on medical device imports.
Long-Term Policy Outlook for U.S. Medical Adhesives
MDUFA VI must be enacted before the current program expires on September 30, 2027, and will set the 510(k) review clock for the following five years. FDA will extend digital submission and AI-assisted review tools, shortening clearance times for low-risk tape and dressing products by 2028.
Section 232 tariff outcomes will push sourcing toward domestic converters and USMCA-compliant suppliers in Mexico. Site-neutral payment policy for outpatient departments will move procedures into ASCs and physician offices, shifting adhesive volume toward single-use closures by 2032.
Frequently Asked Questions
Market Segmentation
- Pressure-Sensitive Adhesives
- Cyanoacrylate Tissue Adhesives
- Fibrin Sealants
- Hydrocolloid Adhesives
- Silicone Adhesives
- Hospitals
- Ambulatory Surgical Centers
- Home Healthcare
- Physician Offices
- Wound Closure
- Transdermal Drug Delivery
- Ostomy and Wound Care
- Device Assembly
Table of Contents
Research Framework and Methodological Approach
Information
Procurement
Information
Analysis
Market Formulation
& Validation
Overview of Our Research Process
MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.
1. Data Acquisition Strategy
Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.
- Company annual reports & SEC filings
- Industry association publications
- Technical journals & white papers
- Government databases (World Bank, OECD)
- Paid commercial databases
- KOL Interviews (CEOs, Marketing Heads)
- Surveys with industry participants
- Distributor & supplier discussions
- End-user feedback loops
- Questionnaires for gap analysis
Analytical Modeling and Insight Development
After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.
2. Market Estimation Techniques
MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.
Bottom-up Approach
Aggregating granular demand data from country level to derive global figures.
Top-down Approach
Breaking down the parent industry market to identify the target serviceable market.
Supply Chain Anchored Forecasting
MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.
Supply-Side Evaluation
Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.
3. Market Engineering & Validation
Market engineering involves the triangulation of data from multiple sources to minimize errors.
Extensive gathering of raw data.
Statistical regression & trend analysis.
Cross-verification with experts.
Publication of market study.
Client-Centric Research Delivery
MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.